EPL Balanced Scorecard
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Unlock the Full Balanced Scorecard for Deeper Strategic Insight
This EPL Balanced Scorecard Analysis helps you quickly understand the company's financial, customer, internal process, and learning and growth priorities in one structured format. This page already shows a real preview of the analysis, so you can review the actual content before buying. Purchase the full version to get the complete ready-to-use report.
Benefits
Pharma Portfolio Scaling
Pharma Portfolio Scaling keeps EPL focused on higher-margin pharma and beauty lines, not low-margin oral care. That matters because management is targeting non-oral care categories to be over 45% of global earnings by end-2026. In FY25, this kind of mix shift should lift profitability faster than volume alone.
ESG Metric Quantification
Embedding ESG targets into the balanced scorecard lets EPL track the adoption rate of the Platina recyclable range by market and customer tier, so managers can see where eco-friendly uptake is fastest. It also shows how many top-tier FMCG clients shift to 100 percent recyclable solutions, which links sustainability performance to revenue mix and retention. That makes ESG progress measurable, comparable, and tied to commercial results.
Global Operational Synergy
The balanced scorecard ties together more than 20 plants across 11 countries, so EPL can keep product quality and output aligned. It also gives managers one standard yardstick to compare shop-floor productivity in US plants with faster-growing emerging-market sites. That helps spot gaps faster and push best practices across the network without losing consistency.
Accelerated R&D Outcomes
In FY25, EPL's focus on cycle-time tracking can shorten the path from prototype to scale, which matters in complex packaging where trial runs, tooling tweaks, and validation can drag on for months. Faster R&D execution helps EPL move specialized laminated tubes into commercial production sooner, protecting margin and share in higher-value niches. It also supports a tighter internal process scorecard by linking innovation speed to fewer delays, lower rework, and stronger moat-building.
Customer Wallet-Share Metrics
Customer wallet-share metrics matter because P&G and Unilever are huge anchors: P&G reported FY2025 net sales of $84.3 billion, while Unilever posted FY2025 turnover of €60.8 billion. Tracking service levels, fill rates, and on-time delivery against a 90%+ retention target helps EPL spot slipping share before contracts move to rivals in regional hubs. That keeps key-account income stable and lowers churn risk in its biggest lanes.
EPL's FY25 Scorecard: Growth, Share, and Plant Output in Focus
Benefits: EPL's balanced scorecard makes FY25 growth easier to steer by linking pharma mix, ESG adoption, and plant output to cash results. With P&G FY2025 net sales at $84.3 billion and Unilever FY2025 turnover at €60.8 billion, key-account tracking helps protect share in large lanes. It also speeds issue spotting across 20+ plants in 11 countries.
| Benefit | FY25 signal |
|---|---|
| Mix shift | Non-oral care >45% earnings by 2026 |
| Key accounts | P&G $84.3B; Unilever €60.8B |
| Operations | 20+ plants, 11 countries |
What is included in the product
Detailed Word Document
Editable Excel File
Drawbacks
Raw Material Volatility
Raw material volatility makes EPL's FY2025 efficiency ratios noisy: polymer and aluminum price swings can lift input costs faster than output pricing, so plant-level KPIs can worsen even when operations stay steady. In the petroleum-derivative supply chain, fixed KPIs miss these external shocks, especially during inflation spikes that hit resin and foil contracts at different times. That means margin and throughput targets need commodity-aware adjustments, or they can misread true performance.
Fragmented Data Integration
Fragmented data integration makes EPL's 2025 scorecard slower and pricier to run, because real-time plant data must be pulled from separate legacy systems across global units. That administrative drag can add six-figure integration costs and still leave managers with late or mismatched KPI reads. The result is weaker response speed, and a bad regional report can delay corrective action until the next cycle.
Near-Term ROIC Bias
Near-term ROIC bias can push EPL to favor quick returns over the long payback needed for experimental sustainable materials. That is a real risk because low-carbon scale-up is still capital heavy: the IEA said clean energy investment would exceed $2 trillion in 2025, showing how much cash these shifts absorb. Short-term margin targets can then slow trials, pilot lines, and supplier changes that protect future growth.
Localized Market Blindness
Localized market blindness weakens EPL's scorecard because China's pharma rules, pricing, and approvals can differ sharply from global assumptions. A single global template can slow execution when local teams must wait for extra compliance checks or adapt campaigns to region-specific buyer behavior. In pharma, even a small delay can push launches past a quarter and cut the 2025 revenue window.
Complex Weighting Requirements
Complex weighting is a weak spot in EPL balanced scorecards because sustainability, cost leadership, and fast innovation pull in different directions. If the weights are even slightly off, managers chase easy operational wins instead of the few choices that drive long-term growth. In 2025 planning cycles, that usually means more time spent tuning scorecards than improving margins or product speed.
- Conflicting goals distort priorities
- Small wins can crowd out growth
EPL's 2025 Scorecard Risks Mask Margin Strain and Slow Innovation
EPL's 2025 Balanced Scorecard can understate real strain when polymer and aluminum costs swing faster than pricing, so margin and throughput KPIs can look worse even if plants hold steady. Fragmented legacy data also slows reads across global units, and short-term ROIC pressure can crowd out longer-payback sustainable materials work.
| Drawback | 2025 data point | Effect |
|---|---|---|
| Input volatility | IEA clean energy investment > $2T | Cost noise |
| Data silos | Multi-system global feeds | Late KPIs |
| Short-term bias | Long payback capex | Slower innovation |
Get Your Copy
EPL Reference Sources
This preview shows the actual EPL Balanced Scorecard Analysis document you'll receive after purchase. There are no placeholder sections or sample-only pages – what you see is the real report. Once you complete checkout, the full version is unlocked for immediate download.
Frequently Asked Questions
EPL tracks the transition to recyclable products through its Platina initiatives using dedicated scorecard pillars focused on ESG performance. The company aims for a 100 percent recyclable portfolio by mid-2026. This allows executives to measure progress against shipping over 1.2 billion sustainable tubes annually, ensuring environmental commitments translate directly into measurable operational output and global revenue growth.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.